Literature DB >> 11878509

Human natural killer cell receptors and signal transduction.

K S Campbell1, M Colonna.   

Abstract

Natural killer (NK) cells express numerous receptors, which continually engage with ligands on cell surfaces. Until 1995, only a handful of these receptors were characterized and the molecular basis of NK cell activation was obscure. Recently, considerable advances have been made in characterizing the receptor repertoire on human NK cells. Both activating and inhibitory receptors can transduce positive or negative signals to regulate NK cell cytotoxicity and cytokine release responses. The inhibitory receptors normally predominate in this balance of signals. Certain tumor cells and virally infected cells that lack major histocompatibility complex (MHC) class I molecules, however, can rapidly trigger NK cell activation. The basis of this activation is the loss of negative signals that are normally transmitted by MHC class I-binding inhibitory receptors, and the corresponding domination of activating receptor signals. While ligand specificity for a number of the recently described receptors is still a mystery, their signal transduction properties have begun to be defined. The dynamic crosstalk between these receptors ultimately governs the NK cell activation state. Although the complexities of NK cell signalling are only marginally understood, several overall themes have been defined by characterizing the roles of distinct pathways during NK cell responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11878509     DOI: 10.3109/08830180109054413

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  12 in total

1.  Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.

Authors:  Giuseppe Sconocchia; Giulio Cesare Spagnoli; Domenico Del Principe; Soldano Ferrone; Maurizio Anselmi; Wachanan Wongsena; Valerio Cervelli; Elke Schultz-Thater; Stephen Wyler; Vincenza Carafa; Holger Moch; Luigi Terracciano; Luigi Tornillo
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

2.  Association of KIR3DL1/S1 and HLA-Bw4 with CD4 T cell counts in HIV-infected Mexican mestizos.

Authors:  Daniel Hernández-Ramírez; Mario A Esparza-Pérez; José L Ramirez-Garcialuna; J Rafael Arguello; Peter B Mandeville; Daniel E Noyola; Christian A García-Sepúlveda
Journal:  Immunogenetics       Date:  2015-06-03       Impact factor: 2.846

3.  High KIR diversity in Amerindians is maintained using few gene-content haplotypes.

Authors:  Ketevan Gendzekhadze; Paul J Norman; Laurent Abi-Rached; Zulay Layrisse; Peter Parham
Journal:  Immunogenetics       Date:  2006-05-05       Impact factor: 2.846

4.  Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections.

Authors:  Saray Aranda-Romo; Christian A Garcia-Sepulveda; Andreu Comas-García; Fernando Lovato-Salas; Mariana Salgado-Bustamante; Alejandro Gómez-Gómez; Daniel E Noyola
Journal:  Immunogenetics       Date:  2012-06-01       Impact factor: 2.846

5.  Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.

Authors:  Liat Binyamin; R Katherine Alpaugh; Tracey L Hughes; Charles T Lutz; Kerry S Campbell; Louis M Weiner
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

6.  The chicken immunoregulatory receptor families SIRP, TREM, and CMRF35/CD300L.

Authors:  Birgit C Viertlboeck; Ramona Schmitt; Thomas W Göbel
Journal:  Immunogenetics       Date:  2006-02-22       Impact factor: 2.846

7.  Functional requirements for inhibitory signal transmission by the immunomodulatory receptor CD300a.

Authors:  Karen E DeBell; Venkateswara R Simhadri; John L Mariano; Francisco Borrego
Journal:  BMC Immunol       Date:  2012-04-26       Impact factor: 3.615

8.  KIR gene diversity in Mexican mestizos of San Luis Potosí.

Authors:  Diana Lorena Alvarado-Hernández; Daniel Hernández-Ramírez; Daniel Ernesto Noyola; Christian Alberto García-Sepúlveda
Journal:  Immunogenetics       Date:  2011-06-04       Impact factor: 3.330

9.  Natural killer cells and autoimmunity.

Authors:  Anthony R French; Wayne M Yokoyama
Journal:  Arthritis Res Ther       Date:  2003-12-09       Impact factor: 5.156

10.  Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy.

Authors:  Anhua Wu; Steve Wiesner; Jing Xiao; Katya Ericson; Wei Chen; Walter A Hall; Walter C Low; John R Ohlfest
Journal:  J Neurooncol       Date:  2006-11-01       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.